ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

644
Analysis
Health Care • South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
•11 Oct 2016 01:22

Important Regulatory Changes for IPOs on the KOSDAQ Exchange

There are some important regulatory changes that are coming to the IPOs market for companies listing on the KOSDAQ exchange in Korea. Although the...

Logo
379 Views
Share
bearish•Samsung Biologics
•05 Oct 2016 12:01

Samsung BioLogics IPO Part 3 - Valuation

Samsung BioLogics has just filed an IPO report. I will summarize Samsung BioLogics IPO report in the following three parts:Part 1 - IPO...

Logo
457 Views
Share
bearish•Samsung Biologics
•04 Oct 2016 07:43

Samsung BioLogics IPO Price, Capital Investment Plan & Valuation Issue

In a regulatory filing (last Friday), Samsung Biologics announced its plan to raise â‚©1.23tril (US$1.12bil) of new shares. Samsung BioLogics plans...

Logo
379 Views
Share
•04 Oct 2016 03:57

Korea Stock Market Monthly Recap #6 - (September 2016)

The six major events in the Korea Stock Market in September were as follows: LG Chem-LG Life Sciences merger, Hanjin Shipping applying for court...

Logo
275 Views
Share
•17 Sep 2016 22:47

Korea's Foreign Direct Investment Trend

LS Cable & System Asia Ltd (229640 KS) and Hwaseung Enterprise Co. are two Vietnam related stocks that will be listed on the Korea Stock Market...

Logo
287 Views
Share
x